A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 1171-1180

  Lopez Quintero, Sandra V ^a   Ji, Xin Ying ^a   Antonetti, David A ^b   Tarbell, John M ^a  

^a City College of New York   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYTETRAMETHYLRODAMINE; CLAUDIN 5; DEXTRAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; LOW DENSITY LIPOPROTEIN; PROTEIN ZO1; REAGENT; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; 5 CARBOXYTETRAMETHYLRHODAMINE SUCCINIMIDYL ESTER; 5-CARBOXYTETRAMETHYLRHODAMINE SUCCINIMIDYL ESTER; RHODAMINE; VASCULOTROPIN A;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD RETINA BARRIER; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DIFFUSION; ENDOTHELIUM CELL; HYDRAULIC CONDUCTIVITY; HYDROSTATIC PRESSURE; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; MACROMOLECULE; MODEL; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RETINAL ENDOTHELIAL CELL; STEADY STATE; WATER FLOW; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; BODY WATER; CAPILLARY PERMEABILITY; CATTLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; HYPERGLYCEMIA; METABOLISM; NICK END LABELING; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; BODY WATER; CAPILLARY PERMEABILITY; CATTLE; CELLS, CULTURED; DEXTRANS; ENDOTHELIUM, VASCULAR; GLUCOSE; HYPERGLYCEMIA; IN SITU NICK-END LABELING; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; RETINAL VESSELS; RHODAMINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953291729     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5971     Document Type: Article

References (50)

1. Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Acta Ophthalmol (Copenh). 1994;72:663-667.
2. Fujita H. Vascular endothelial cell dysfunction in diabetes mellitus (in Japanese). Nippon Rinsho. 1999;57:573-577.
3. Brausewetter F, Jehle PM, Jung MF, et al. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Horm Metab Res. 2001;33:713-720.
4. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
5. Frank RN. On the pathogenesis of diabetic retinopathy. Ophthalmology. 1984;91:626-634.
6. Mondal LK, Baidya KP, Bhaduri G, Bandyopadhyay R, Bhattacharya B. Alteration of timing of secretion of vascular endothelial growth factors is responsible for progression of diabetic retinopathy. J Indian Med Assoc. 2008;106:508, 510, 515.
7. Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42:2408-2413.
8. Gardner TW, Antonetti DA, Barber AJ, Lieth E, Tarbell JA. The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol. 1999;97: 229-237.
9. Curry FE, Michel CC. A fiber matrix model of capillary permeability. Microvasc Res. 1980;20:96 -99.
10. Gillies MC, Su T, Naidoo D. Electrical resistance and macromolecular permeability of retinal capillary endothelial cells in vitro. Curr Eye Res. 1995;14:435-442.
11. Haselton FR, Dworska EJ, Hoffman LH. Glucose-induced increase in paracellular permeability and disruption of beta-receptor signaling in retinal endothelium. Invest Ophthalmol Vis Sci. 1998;39: 1676-1684.
12. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57:1952-1965.
13. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes. 1998;47:1953-1959.
14. Barber AJ, Antonetti DA. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats. Invest Ophthalmol Vis Sci. 2003;44:5410-5416.
15. Sill HW, Chang YS, Artman JR, Frangos JA, Hollis TM, Tarbell JM. Shear stress increases hydraulic conductivity of cultured endothelial monolayers. Am J Physiol. 1995;268:H535-H543.
16. Cancel LM, Fitting A, Tarbell JM. In vitro study of LDL transport under pressurized (convective) conditions. Am J Physiol Heart Circ Physiol. 2007;293:H126-H132.
17. Curry FE. Mechanics and thermodynamics of transcapillary exchange. Microcirculation, part 1. The Cardiovascular System. Vol. 4. 1984:309-374. Handbook of Physiology; section 2.
18. Adamson RH, Michel CC. Pathways through the intercellular clefts of frog mesenteric capillaries. J Physiol. 1993;466:303-327.
19. Chen YL, Jan KM, Lin HS, Chien S. Ultrastructural studies on macromolecular permeability in relation to endothelial cell turnover. Atherosclerosis. 1995;118:89-104.
20. Fu BM, Weinbaum S, Tsay RY, Curry FE. A junction-orifice-fiber entrance layer model for capillary permeability: application to frog mesenteric capillaries. J Biomech Eng. 1994;116:502-513.
21. Ward BJ, Bauman KF, Firth JA. Interendothelial junctions of cardiac capillaries in rats: their structure and permeability properties. Cell Tissue Res. 1988;252:57-66.
22. DeMaio L, Tarbell JM, Scaduto RC Jr, Gardner TW, Antonetti DA. A transmural pressure gradient induces mechanical and biological adaptive responses in endothelial cells. Am J Physiol Heart Circ Physiol. 2004;286:H731-H741.
23. Kim MH, Harris NR, Tarbell JM. Regulation of capillary hydraulic conductivity in response to an acute change in shear. Am J Physiol Heart Circ Physiol. 2005;289:H2126-H2135.
24. Rutledge JC, Curry FE, Blanche P, Krauss RM. Solvent drag of LDL across mammalian endothelial barriers with increased permeability. Am J Physiol. 1995;268:H1982-H1991.
25. Rippe B, Kamiya A, Folkow B. Transcapillary passage of albumin, effects of tissue cooling and of increases in filtration and plasma colloid osmotic pressure. Acta Physiol Scand. 1979;105:171-187.
26. Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev. 1994;74:163-219.
27. Rippe B, Stelin G. Simulations of peritoneal solute transport during CAPD: application of two-pore formalism. Kidney Int. 1989;35: 1234-1244.
28. Hamann S, Zeuthen T, La Cour M, et al. Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. Am J Physiol. 1998;274:C1332-C1345.
29. Motulsky E, Koch P, Janssens S, et al. Aquaporin expression in blood-retinal barrier cells during experimental autoimmune uveitis. Mol Vis. 2010;16:602-610.
30. Renkin EM. Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol. 1985;58:315-325.
31. Michel CC, Curry FE. Microvascular permeability. Physiol Rev. 1999;79:703-761.
32. Weinbaum S, Tsay R, Curry FE. A three-dimensional junction-porematrix model for capillary permeability. Microvasc Res. 1992;44: 85-111.
33. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003; 161:653-660.
34. Lakshminarayanan S, Antonetti DA, Gardner TW, Tarbell JM. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO. Invest Ophthalmol Vis Sci. 2000;41: 4256-4261.
35. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: an overview. Clin Cardiol. 1991; 14:I1-16.
36. Wiklund O, Carew TE, Steinberg D. Role of the low density lipoprotein receptor in penetration of low density lipoprotein into rabbit aortic wall. Arteriosclerosis. 1985;5:135-141.
37. Leto G, Pricci F, Amadio L, et al. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev. 2001;17:448-458.
38. Shivers RR. The effect of hyperglycemia on brain capillary permeability in the lizard, Anolis carolinensis: a freeze-fracture analysis of blood-brain barrier pathology. Brain Res. 1979;170:509-522.
39. Vorbrodt AW, Dobrogowska DH, Tarnawski M, Meeker HC, Carp RI. Immunogold study of altered expression of some interendothelial junctional molecules in the brain blood microvessels of diabetic scrapie-infected mice. J Mol Histol. 2006;37:27-35.
40. Rincon-Choles H, Vasylyeva TL, Pergola PE, et al. ZO-1 expression and phosphorylation in diabetic nephropathy. Diabetes. 2006;55: 894-900.
41. Grammas P, Riden M. Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brainderived endothelial cells. Microvasc Res. 2003;65:18-23.
42. Villarroel M, Garcia-Ramirez M, Corraliza L, Hernandez C, Simo R. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinol Nutr. 2009;56:53-58.
43. Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol. 1997;273: H2224-H2231.
44. Mathews MK, Merges C, McLeod DS, Lutty GA. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38:2729-2741.
45. Gilbert RE, Vranes D, Berka JL, et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998;78:1017-1027.
46. Williams B, Gallacher B, Patel H, Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes. 1997;46:1497-1503.
47. Schrufer TL, Antonetti DA, Sonenberg N, Kimball SR, Gardner TW, Jefferson LS. Ablation of 4E-BP1/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture. Diabetes. 2010;59:2107-2116.
48. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci. 2006;47:5106-5115.
49. Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284:21036-21046.
50. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of TJ proteins occludin and zonula occluden, 1: a potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem. 1999;274:23463-23467.